Igal Nevo

1.5k total citations
24 papers, 1.3k citations indexed

About

Igal Nevo is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Igal Nevo has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Igal Nevo's work include Receptor Mechanisms and Signaling (14 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Neuropeptides and Animal Physiology (8 papers). Igal Nevo is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Neuropeptides and Animal Physiology (8 papers). Igal Nevo collaborates with scholars based in Israel, France and Germany. Igal Nevo's co-authors include Tomer Avidor‐Reiss, Zvi Vogel, Rivka Levy, Michael Bayewitch, Thomas Pfeuffer, Noa Matus-Leibovitch, William F. Simonds, Zvi Vogel, Man Hee Rhee and M. Hamon and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and FEBS Letters.

In The Last Decade

Igal Nevo

24 papers receiving 1.3k citations

Peers

Igal Nevo
Michael Pfenning United States
Lane D. Hirning United States
Hsiang-En Wu United States
Eric Erbs France
Daniel C. Broom United States
Robert D. Pinnock United Kingdom
Loh Hh United States
Kristin K. Mehmert United States
Michael Pfenning United States
Igal Nevo
Citations per year, relative to Igal Nevo Igal Nevo (= 1×) peers Michael Pfenning

Countries citing papers authored by Igal Nevo

Since Specialization
Citations

This map shows the geographic impact of Igal Nevo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igal Nevo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igal Nevo more than expected).

Fields of papers citing papers by Igal Nevo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igal Nevo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igal Nevo. The network helps show where Igal Nevo may publish in the future.

Co-authorship network of co-authors of Igal Nevo

This figure shows the co-authorship network connecting the top 25 collaborators of Igal Nevo. A scholar is included among the top collaborators of Igal Nevo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igal Nevo. Igal Nevo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhee, Man Hee, Igal Nevo, Rivka Levy, & Zvi Vogel. (2000). Role of the highly conserved Asp‐Arg‐Tyr motif in signal transduction of the CB2 cannabinoid receptor. FEBS Letters. 466(2-3). 300–304. 37 indexed citations
3.
Nevo, Igal, Tomer Avidor‐Reiss, Rivka Levy, Michael Bayewitch, & Zvi Vogel. (2000). Acute and chronic activation of the μ-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes. Neuropharmacology. 39(3). 364–371. 23 indexed citations
4.
Rhee, Man Hee, Igal Nevo, Tomer Avidor‐Reiss, Rivka Levy, & Zvi Vogel. (2000). Differential Superactivation of Adenylyl Cyclase Isozymes after Chronic Activation of the CB1Cannabinoid Receptor. Molecular Pharmacology. 57(4). 746–752. 44 indexed citations
5.
Rhee, Man Hee, Igal Nevo, Michael Bayewitch, Orna Zagoory, & Zvi Vogel. (2000). Functional Role of Tryptophan Residues in the Fourth Transmembrane Domainof the CB2 Cannabinoid Receptor. Journal of Neurochemistry. 75(6). 2485–2491. 35 indexed citations
6.
Rhee, Man Hee, Igal Nevo, Tomer Avidor‐Reiss, Rivka Levy, & Zvi Vogel. (2000). Differential Superactivation of Adenylyl Cyclase Isozymes after Chronic Activation of the CB1 Cannabinoid Receptor. Molecular Pharmacology. 57(4). 746–752. 5 indexed citations
7.
Eckhardt, Klaus, Igal Nevo, Rivka Levy, et al.. (2000). Morphine‐related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration. FEBS Letters. 470(3). 309–314. 9 indexed citations
8.
Nevo, Igal, Tomer Avidor‐Reiss, Rivka Levy, et al.. (1998). Regulation of Adenylyl Cyclase Isozymes on Acute and Chronic Activation of Inhibitory Receptors. Molecular Pharmacology. 54(2). 419–426. 67 indexed citations
9.
Bayewitch, Michael, Tomer Avidor‐Reiss, Rivka Levy, et al.. (1998). Differential Modulation of Adenylyl Cyclases I and II by Various Gβ Subunits. Journal of Biological Chemistry. 273(4). 2273–2276. 72 indexed citations
10.
Bayewitch, Michael, et al.. (1998). Inhibition of adenylyl cyclase isoforms V and VI by various Gbg subunits. 17 indexed citations
11.
Matus-Leibovitch, Noa, Igal Nevo, & Zvi Vogel. (1997). Differential distribution of synapsin IIa and IIb mRNAs in various brain structures and the effect of chronic morphine administration on the regional expression of these isoforms. Molecular Brain Research. 45(2). 301–316. 21 indexed citations
12.
Avidor‐Reiss, Tomer, et al.. (1997). Opiate-induced Adenylyl Cyclase Superactivation Is Isozyme-specific. Journal of Biological Chemistry. 272(8). 5040–5047. 150 indexed citations
13.
Nevo, Igal, Chrystel Becker, Michel Hamon, & Jean‐Jacques Benoliel. (1996). Stress‐ and Yohimbine‐Induced Release of Cholecystokinin in the Frontal Cortex of the Freely Moving Rat: Prevention by Diazepam but Not Ondansetron. Journal of Neurochemistry. 66(5). 2041–2049. 30 indexed citations
14.
Laporte, Anne‐Marie, Cécile M. Doyen, Igal Nevo, et al.. (1996). Autoradiographic mapping of serotonin 5-HT1A, 5-HT1D, 5-HT2A and 5-HT3 receptors in the aged human spinal cord. Journal of Chemical Neuroanatomy. 11(1). 67–75. 38 indexed citations
15.
Avidor‐Reiss, Tomer, Igal Nevo, Rivka Levy, Thomas Pfeuffer, & Zvi Vogel. (1996). Chronic Opioid Treatment Induces Adenylyl Cyclase V Superactivation. Journal of Biological Chemistry. 271(35). 21309–21315. 176 indexed citations
16.
Nevo, Igal. (1995). Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochemistry International. 26(4). 305–336. 223 indexed citations
17.
Nevo, Igal, Xavier Langlois, Anne‐Marie Laporte, et al.. (1995). Chronic alcoholization alters the expression of 5-HT1A and 5-HT1B receptor subtypes in rat brain. European Journal of Pharmacology. 281(3). 229–239. 51 indexed citations
18.
Avidor‐Reiss, Tomer, Michael Bayewitch, Rivka Levy, et al.. (1995). Adenylylcyclase Supersensitization in μ-Opioid Receptor-transfected Chinese Hamster Ovary Cells Following Chronic Opioid Treatment. Journal of Biological Chemistry. 270(50). 29732–29738. 158 indexed citations
19.
Pohl, Michel, E. Collin, S. Bourgoin, et al.. (1994). Expression of Preproenkephalin A Gene and Presence of Met‐Enkephalin in Dorsal Root Ganglia of the Adult Rat. Journal of Neurochemistry. 63(4). 1226–1234. 27 indexed citations
20.
Nevo, Igal & S. Parvez. (1994). Changes in brain MAO activity and glycogen levels upon chronic alcoholization of three successive generations of rats. Fundamental and Clinical Pharmacology. 8(4). 347–355. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026